… potential for bias, it is possible that this bias would have also affected our pooled analysis.
No quality analysis of the included studies was undertaken; therefore, it is not possible to …

… NSCLC provides an expanded dataset for analysis. This paper describes an … EGFR TKIs
in patients with EGFR mutation-positive NSCLC, and reports the results of a pooled analysis of …

… who were genotyped for EGFR mutations and selected to receive gefitinib based on the
presence of an activating somatic mutation. We believe that our pooled analysis, combining 101 …

… manifestation of ILD in unselected patients treated with EGFR-TKIs. Our pooled analysis of
EGFR-TKI treatment in EGFR mutation-positive NSCLC patients found that the frequency of all…

… are pooled. In the present study, the pooled-data analysis showed that EGFR mutations … ,
we did not find any significant association between EGFR mutations and acinar, papillary and …

… Our pooled analysis indicated that neoadjuvant EGFR-TKI therapy may provide a feasible
treatment modality for patients with resectable or potentially resectable EGFR-mutant NSCLC, …

… In conclusion, our pooled analysis demonstrated that EGFR-TKIs are an … EGFR mutations.
Therefore, we emphasize that patients with NSCLC should be tested for EGFR mutations. The …

… tumors harboring EGFR mutation were non-adenocarcinoma NSCLC. A pooled analysis was
… non-adenocarcinoma NSCLC patients harboring EGFR mutations. A systematic search of …

… the ability to identify EGFR mutations. Objective: This pooled analysis aims to evaluate the …
and the sensitivity of ctDNA analysis in detecting EGFR mutations in NSCLC patients. Methods…

… Our pooled analysis shows that the realization of SCLC phenotype mostly takes more
than 1 year, and the prognosis of patients after SCLC diagnosis is worse than primary SCLC. …